no need to bash LMNL$490.00 52 week high vs $7.05 low today.
No news of any consequence with regards to products in years.
Ryplazim process control additions requested by FDA over a year plus ago and nothing to date. Batches will need to be produced, polished and filled before BLA can be submitted. No information on what is taking so long from LMNL new management.
4050 Alstrom went from talking about fast track to where we havent even finished talking to FDA and EMA about what is needed for phase 3.
Not sure what to make of amended loan agreement. Waiting for more information to come out.
Royalties on revenue of commercialized products going to SALP until approx 2033. Don't remember that ever being discussed in the open.
I like it when I can see everything above board. IMHO